Once-daily mesalamine (Lialda) for ulcerative colitis

Medical Letter on Drugs and Therapeutics

Volumn 49, Issue 1257, 2007, Pages 25-26

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BALSALAZIDE; MERCAPTOPURINE; MESALAZINE; OLSALAZINE; PLACEBO; SALAZOSULFAPYRIDINE; SULFAPYRIDINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; CLINICAL TRIAL; DIARRHEA; DRUG ABSORPTION; DRUG COST; DRUG DOSE COMPARISON; DRUG MECHANISM; DYSPEPSIA; FLATULENCE; HEADACHE; HUMAN; INTERSTITIAL NEPHRITIS; PH; REMISSION; SHORT SURVEY; SKIN ALLERGY; TREATMENT DURATION; ULCERATIVE COLITIS; ARTICLE; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG INTERACTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HUMANS; MESALAMINE; RANDOMIZED CONTROLLED TRIALS;

EID: 34047107630     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther 1992; 34:80.
2. Oral balsalazide (Colazal) for ulcerative colitis. Med Lett Drugs Ther 2001; 43:62.
3. Olsalazine for ulcerative colitis. Med Lett Drugs Ther 1990; 32:105.
4. MA Kamm et al. Once-daily, high concentration MMX mesalamine in active ulcerative colitis. Gastroenterology 2007; 132:66.
5. GR Lichtenstein et al. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2007; 5:95.
6. C Prantera et al. A new oral delivery system for 5-ASA: preliminary clinical findings for MMX. Inflamm Bowel Dis 2005; 11:421.
7. PW Lowry et al. Balsalazide and azathioprine or 6-mercaptopurine: evidence for a potentially serious drug interaction. Gastroenterology 1999; 116:1505.